TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing In Diabetic Foot Infection Met Primary Endpoints
March 13th, 2010 admin
TaiGen Biotechnology Co., Ltd. announced the Phase II trial of nemonoxacin (TG-873870) in Diabetic Foot Infection (DFI) with once-a-day dosing met the primary endpoints and showed promising clinical efficacy and good tolerability. Nemonoxacin is a novel non-fluorinated quinolone that has a broad spectrum of activity against gram-positive and gram-negative bacteria and atypical pathogens…
Related Videos from Youtube
Type I diabetes doesn't win!Click here to donate: walk.jdrf.org
The Diabetic Epidemic and What You...Natural health expert Dr. Joseph Mercola talks about preventing and reversing diabetes. To know more about diabetes, visit articles.mercola.com
Diabetes Basics: What Is Diabetes?Learn and know the difference between Type 1 and Type 2 diabetes, as well as what happens to the body when you have diabetes.
What is Diabetes?dLife's Nicole Johnson talks about the different types of diabetes.
Related Posts
Sernova Corp. (TSX VENTURE:SVA) is pleased to report positive results from a long-term study evaluating the safety and efficacy of the Cell Pouch System™ in a pre-clinical model of diabetes…
Read More →
Tranzyme Pharma announced positive top-line results from a Phase 2, double-blind, placebo-controlled study evaluating TZP-102 capsules in diabetic patients with gastroparesis, a serious disorder characterized by the inability of the stomach to empty food efficiently. The study achieved a clinically meaningful and statistically significant improvement...
A study presented at SNM’s 57th Annual Meeting shows that using multiple imaging agents with a hybrid imaging technique can be a valuable tool for accurately diagnosing and determining treatment for a variety of diabetes-associated foot diseases. A common complication from Type 2 diabetes is the decreased ability to heal from even the most minor...
Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) announced the completion of its’ pivotal Phase 2b clinical study of its oral insulin capsule, ORMD-0801. The Company expects to report results from this study within the coming weeks…
Read More →
Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Technologies Ltd., has submitted a Special Protocol Assessment (SPA) for a proposed phase 3 clinical trial to support the U.S. approval of Cogenzia™: Innocoll’s topical antibiotic therapy for the adjuvant treatment of infected diabetic foot ulcers…
Read More →
Ipsen (Paris:IPN) (Euronext: FR0010259150; IPN), a global biopharmaceutical group, today announced that its partner Roche has disclosed results of the phase III T-emerge 3 study in patients with diabetes with taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence. Taspoglutide originating from Ipsen’s...
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and Bayer HealthCare AG announced that VEGF Trap-Eye showed positive results in a Phase 2 study in patients with diabetic macular edema (DME). The primary endpoint of the study, a statistically significant improvement in visual acuity over 24 weeks compared to the standard of care in DME, macular laser...
Bayer HealthCare AG and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that VEGF Trap-Eye showed positive results in a Phase II study in patients with Diabetic Macular Edema (DME). The primary endpoint of the study, a statistically significant improvement in visual acuity over 24 weeks compared to the standard of care in DME, macular laser...
Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of alternative drug delivery systems, announced that the paper entitled, “Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects,” authored by Dr. Roy Eldor, Dr. Miriam Kidron and Dr. Ehud Arbit, was accepted and published...
Sernova Announces Interim Results From Key Preclincal Study With Its Proprietary Cell Pouch SystemTM
Sernova Corp. (TSX VENTURE:SVA) today reported interim results from a key porcine diabetes study evaluating the safety and efficacy of the Cell Pouch System™…
Read More →
Related Tweets from Twitter
|
sandroandrade09 (Sandro Andrade) : RT @oliberal: O chef paraense Paulo Martins,faleceu nesta madrugada,aos 64 anos de idade, devido a complicaes de diabetes. #drops.. Updated : 2010-09-09T13:01:01Z | Reply | View Tweet |
|
diabetesnc (DiabetesNsCuidamos) : Carambola e diabetes podem ser problema. O consumo da fruta pode at matar pacientes com insuficincia renal. http://ow.ly/2zQNG.. Updated : 2010-09-09T13:00:50Z | Reply | View Tweet |
|
Pretty_AP (Amy Perry) : I have when people pronounce "diabetes," "die-uh-beet-iss".. Updated : 2010-09-09T13:00:44Z | Reply | View Tweet |
|
Eanna_McKnight (Eanna McKnight) : Diabetes drug available on NHS months after experts call for... http://lnkd.in/ic5Aqk.. Updated : 2010-09-09T13:00:17Z | Reply | View Tweet |
|
mnt_diabetes (MNT Diabetes News) : Risk Of Gestational Diabetes, Cesarean Section, Reduced In The Obese By Bariatric Operations http://mnt.to/3Jss #diabetes.. Updated : 2010-09-09T13:00:10Z | Reply | View Tweet |
Related News from Digg
Leave a comment
| Trackback
